Crispr stock 5 year forecast

Author: rncu

August undefined, 2024

WebNext reporting date: May 8, 2024: EPS forecast (this quarter)-$0.48: Annual revenue (last year) $13.9M: Annual profit (last year)-$99.4M: Net profit margin WebJan 30, 2024 · For the nine-month period ending Sept. 30, 2024, the company's revenue just from that segment alone has topped nearly $500 million -- a 288% year-over-year increase.

CRSP Stock News CRISPR THERAPEUTICS Stock Price Today

Web2 days ago · The MarketWatch News Department was not involved in the creation of this content. Apr 12, 2024 (The Expresswire) -- The Report on “CRISPR and CRISPR-Associated (Cas) Genes Market” Research ... WebCRISPR Therapeutics Stock Forecast and Price Target. ... In the last year, CRISPR Therapeutics's Price has decreased by 100.00%, going from $17.55 to $0.00. In the next … infostretch hyderabad office address

Outlook on the CRISPR Gene Editing Global Market to 2030

Web4 hours ago · This company is expected to post quarterly loss of $1.67 per share in its upcoming report, which represents a year-over-year change of +28%. Revenues are … WebFeb 8, 2024 · The global CRISPR gene editing market was valued at $846.2 million in 2024 and is expected to reach $10,825.1 million by 2030, registering a CAGR of 26.86% during the forecast. The development of ... WebOn average, Wall Street analysts predict. that Crispr Therapeutics Ag's share price could reach $71.26 by Apr 3, 2024. The average Crispr Therapeutics Ag stock price … infostretch in bangalore

CRISPR and CRISPR-Associated (Cas) Genes Market 2024-2030

WebMar 29, 2024 · Out of 197 instances in the last 4 years that CRISPR Therapeutics AG stock saw a 5-day decline of 7.3% or more, 112 of them resulted in CRSP stock rising over … mistlands foodWebApr 10, 2024 · See the latest CRISPR Therapeutics AG stock price (NASDAQ:CRSP), related news, valuation, dividends and more to help you make your investing decisions. ... Year Range 38.94 – 86.95. infostretch engage login

"WebApr 13, 2024 · The firm’s revenue for the quarter was down 53.5% compared to the same quarter last year. Research analysts forecast that CRISPR Therapeutics will post -7.35 EPS for the current year. ... Insiders sold a total of 75,000 shares of company stock worth $3,604,500 over the last three months. 5.30% of the stock is currently owned by … " - Crispr stock 5 year forecast

Crispr stock 5 year forecast

CRISPR Therapeutics AG (CRSP) stock price prediction is …

Web17 hours ago · Stock Market Near Highs Ahead Of Bank News; Oprah Winfrey Stock Up 82% On 883% Growth Forecast. The stock market neared weekly highs Thursday while rising layoffs stoked recession fears. Goldman ... WebApr 13, 2024 · The firm's revenue for the quarter was down 53.5% compared to the same quarter last year. Research analysts forecast that CRISPR Therapeutics will post -7.35 …

Did you know?

Web1 day ago · The CRISPR technology market size is forecasted to increase by USD 2.88 billion from 2024 to 2026, at a CAGR of 19.34%, according to a recent market study by Technavio. The growth of the market ... WebApr 9, 2024 · CRISPR previously forecast that exa-cel has a "multibillion-dollar opportunity," but that could take years to realize. Plus the company will split profits with Vertex -- it will take 60%, leaving ...

WebFind the latest Earnings Report Date for CRISPR Therapeutics AG Common Shares (CRSP) at Nasdaq.com. WebApr 12, 2024 · To see how CRISPR Therapeutics AG stock has been performing today in comparison to its peers in the industry, here are the numbers: CRSP stock’s performance was -1.40% at last check in today’s session, and -27.34% in the past year, while Pieris Pharmaceuticals Inc. (PIRS) has been trading -0.88% in recent session and positioned …

WebMar 18, 2024 · CRSP stock forecast for 2024 – 2027. Last updated: March 18, 2024. CRSP. CRISPR Therapeutics AG. 45.74 D 0.77% (0.35) Are you interested in CRISPR Therapeutics AG stocks prediction? If yes, then on this page you will find useful information about the dynamics of the CRSP stock price in 2024-2027. Is CRSP a good long term … WebApr 9, 2024 · CRISPR previously forecast that exa-cel has a "multibillion-dollar opportunity," but that could take years to realize. Plus the company will split profits with Vertex -- it will take 60%, leaving ...

WebApr 4, 2024 · The CRISPR Therapeutics stock prediction results are shown below and presented as a graph, table and text information. CRISPR Therapeutics stock forecasts …

WebStock Price Forecast. The 26 analysts offering 12-month price forecasts for CRISPR Therapeutics AG have a median target of 72.50, with a high estimate of 220.00 and a … infostretch igniteWebApr 10, 2024 · Since 1988 it has more than doubled the S&P 500 with an average gain of +24.52% per year. These returns cover a period from January 1, 1988 through February 6, 2024. mistlands crafting valheimWebCRSP Stock 12 Months Forecast. Based on 17 Wall Street analysts offering 12 month price targets for Crispr Therapeutics AG in the last 3 months. The average price target is … mistlands fishing baitWebApr 30, 2024 · At its current price of $131.88 per share and the market cap of $10 billion, CRISPR Therapeutics AG stock is estimated to be significantly overvalued. GF Value for CRISPR Therapeutics AG is shown ... mistlands food recipesWebApr 10, 2024 · According to 35 stock analysts, the average 12-month stock price forecast for CRSP stock is $85.88, which predicts an increase of 88.42%. The lowest target is … infostretch founded inWebJan 18, 2024 · Yahoo Finance. The above is based on 19 Wall Street analysts offering 12-month price targets for CRISPR Therapeutics in the last 3 months. The average price target is $149.11 with a high forecast ... mistlands extractorWebApr 4, 2024 · The weighted average target price per CRISPR Therapeutics share in Oct 2026 is: 50.23. In Oct, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 10.376% volatility is expected. Pessimistic target level: 47.90. Optimistic target level: 53.44. mistlands how to see